Guidehouse’s Post

The healthcare landscape is changing. A strong clinical profile isn't enough—biotech firms need to take a more dynamic approach to product launch and commercialization: https://lnkd.in/eh9Rvamr Is your organization planning to launch a new product in 2025? Read our analysis of recent biotech launches and learn why you should be investing in pre-launch market development.

For emerging biotechs bringing niche therapies to market, every launch presents unique challenges. 🔴 Without a standard playbook 📗 for commercialization, success depends on seamless collaboration between home office and field teams to uncover and act on critical, ground-level insights. 🤝 In their latest Pharmaceutical Commerce article, Jennifer Maurer of Legend Biotech and Laura Riccio from Beghou Consulting reveal how strong partnerships and adaptable technology are transforming commercialization—empowering companies to navigate a complex landscape and succeed 👉 https://lnkd.in/gT_kayzM

Within #biopharma, first-time launchers make up a growing percentage of the market, bringing much-needed innovation to areas of unmet need and overall commercial models. According to McKinsey & Company, between 2018 and 2023, roughly 40% of new assets were launched by companies with little to no commercialization experience, almost double the previous 5 years. Any biopharma product launch is a mighty feat, but there are strategies that help set first-time launch leaders apart from their peers, including: 🤝 𝗘𝗮𝗿𝗹𝘆 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗶𝗻 𝗔𝗰𝗰𝗲𝘀𝘀 More successful companies onboarded their access team 4 to 6 months 𝘦𝘢𝘳𝘭𝘪𝘦𝘳 than their less successful peers. What's more, among the least successful cohort, 75% acknowledge that market access engagement was initiated too late. 🎯 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗻𝗲𝘅𝘁-𝗴𝗲𝗻 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝗹 𝗰𝗮𝗽𝗮𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀 Unencumbered by legacy systems, earlier-stage biotechs are making strategic tech investments to support more tailored, digital, patient-centric approaches. This includes investing in commercial infrastructure that provides the internal visibility, control, and data to understand what's working and what's not across the end-to-end patient journey, supporting quick and continuous iteration to optimize resources. Preparing for a product launch? Reach out to learn how Courier Health is helping launch leaders achieve a streamlined, more data-driven patient experience. Full article: https://mck.co/49BAyt7

⚕️💊 7 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐓𝐫𝐞𝐧𝐝𝐬 𝐭𝐨 𝐖𝐚𝐭𝐜𝐡 𝐢𝐧 #2025 💊⚕️ The biopharma industry is at the forefront of innovation, shaping the future of healthcare and investment opportunities. 🔬 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐢𝐧 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 🌍 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐠𝐥𝐨𝐛𝐚𝐥 𝐛𝐢𝐨𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 💡 𝐓𝐡𝐞 𝐢𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐀𝐈 𝐚𝐧𝐝 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡 𝐢𝐧 𝐝𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 For investors, these trends represent exciting possibilities to diversify portfolios and align with cutting-edge developments in the sector. As someone who values strategic financial planning, I’m always looking at how industries like biopharma can create long-term value for clients. 𝐖𝐡𝐚𝐭’𝐬 𝐲𝐨𝐮𝐫 𝐩𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞 𝐨𝐧 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐛𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭𝐬? 𝑳𝒆𝒕’𝒔 𝒄𝒐𝒏𝒏𝒆𝒄𝒕 𝒂𝒏𝒅 𝒅𝒊𝒔𝒄𝒖𝒔𝒔! This article from GEN highlights seven key trends to keep an eye on in 2025: https://lnkd.in/gG6DYBkb #Biopharma #Singapore #Funds #Biopharma #Pharma #Trends2025 #HealthcareInnovation #FinancialPlanning #Wealth

At Genesis Consulting, we specialise in analysing current and emerging disease landscapes. You might be wondering, "Why is this so important?" 🤔 Take a look at the current landscape mind map created by our team to see how it highlights Market Opportunities in Pharma. The pharmaceutical world is evolving faster than ever, and staying ahead means recognizing key areas where innovation can make a real difference. How Genesis Consulting Can Support Your Pharma and Biotech Strategy 📌 Target Screening and Prioritization 📌 Current and Emerging Disease Landscape Analysis 📌 Opportunity Prioritization 📌 Clinical Development and Regulatory Strategy 📌 Due Diligence and In-/Out-Licensing Structuring 📌 Long-Term Portfolio Strategy, Planning, and Optimization Let’s work together to transform challenges into opportunities and pave the way for your success. Ready to unlock your next breakthrough? Reach out to us today! #PharmaStrategy #BiotechSolutions #HealthcareInnovation #Genesis

We are helping medtech, pharmaceutical and healthcare startup journeys easier from pre revenue to revenue stages. If you are building something interesting, we would love to hear from you. Drop us a DM!! #medtech #healthcare #saas #startups

Reading this article on pharma R&D got me thinking that we need to broaden our understanding of strategic investment in pharma. It isn’t just about developing drugs, it’s about focusing resources where they make the biggest impact for patients. For example, often patients fall out of the system due to barriers in diagnosis, especially in rare diseases. Identifying where and why these drop-offs happen is crucial for companies deciding where to focus their investment. For rare diseases, this could mean prioritising early diagnosis, ensuring access to specialists, and getting the right diagnostic tools to the right places. Investing in tools that give a clear view of the patient journey across different markets helps teams focus resources wisely, improving patient outcomes and satisfaction while reducing unnecessary costs. Read the full article here: https://lnkd.in/eGv6haNr #PharmaStrategy #PatientAccess #RareDisease #HealthcareInnovation #PharmaInvestments

Delighted to announce our latest partnership with AstraZeneca providing a unique opportunity for UK start-ups to collaborate with a global pharma company and massively de-risk their technical and commercial development.

Leading biotech firms are taking a more sophisticated, multi-faceted approach to product launch and commercialization in 2025. Learn why your organization may want to invest more resources in shaping the market and streamlining patient access prior to launch.

By integrating Real-world evidence (RWE) into product development strategies, biotech and pharma companies can optimize patient care, enhance drug development and drive measurable outcomes. Discover how AscellaHealth is harnessing real-time data and making a difference with innovative RWE-driven solutions. https://lnkd.in/eYD34VE9 #AscellaHealth #Life Sciences #HealthcareInnovation #RealWorldEvidence #PatientOutcomes